San Francisco, CA, United States of America

Mark Edward Zak

This inventor holds 1 USPTO granted patent and 22 published patent applications, plus 1 CIPO patent. Top assignees: Gilead Sciences, Inc., Nurix Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Edward Zak. Retrieved from https://idiyas.com/inventor/mark-edward-zak-54xkp7px

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Journey of Inventor Mark Edward Zak

Introduction

Mark Edward Zak is a notable figure in the realm of innovation, currently working for the renowned pharmaceutical company, F. Hoffmann-La Roche AG in the United States. Although he has yet to secure any patents, his contributions to the field through collaboration and his role in a prominent company are worthy of recognition.

Latest Patents

As of the current date, Mark Edward Zak does not hold any patents. However, his ongoing work at F. Hoffmann-La Roche AG may lead to innovative developments in the future.

Career Highlights

Throughout his career, Mark has been involved in various projects at F. Hoffmann-La Roche AG. His expertise and dedication to advancing medical science continue to make an impact in his field. Collaborating with talented colleagues, like Nicholas Charles Ray, he remains committed to pushing boundaries in pharmaceutical research.

Collaborations

Working alongside Nicholas Charles Ray, Mark Edward Zak has engaged in several collaborative projects at F. Hoffmann-La Roche AG. Their combined efforts contribute to the innovative environment of the company, ensuring that they stay at the forefront of advancements in healthcare and pharmaceuticals.

Conclusion

Mark Edward Zak, though currently without patents, plays a significant role in the innovation landscape through his work at F. Hoffmann-La Roche AG. His collaborations, especially with Nicholas Charles Ray, showcase his commitment to contributing to the future of pharmaceutical advancements. As he continues on his professional journey, the potential for impactful inventions remains ripe for exploration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…